Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Guided Therapeutics Inc. (GTHP) had Debt to Capital Ratio of -0.01 for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$0.59M |
|
$-1.24M |
|
$0.13M |
|
$0.46M |
|
$1.30M |
|
$-0.71M |
|
$-0.51M |
|
$-1.22M |
|
$-1.22M |
|
$-1.22M |
|
$-1.22M |
|
$-1.22M |
|
$-1.22M |
|
$-0.71M |
|
$-0.63M |
|
78.41M |
|
78.41M |
|
$-0.01 |
|
$-0.01 |
|
| Balance Sheet Financials | |
$0.60M |
|
$0.02M |
|
$0.72M |
|
$1.32M |
|
$6.64M |
|
$0.04M |
|
$0.69M |
|
$7.33M |
|
$-7.62M |
|
$-6.01M |
|
$-6.01M |
|
86.15M |
|
| Cash Flow Statement Financials | |
$-1.07M |
|
$-0.00M |
|
$0.74M |
|
$0.39M |
|
$0.06M |
|
$-0.33M |
|
$0.38M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.09 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-0.01 |
-0.37 |
|
77.46% |
|
-120.34% |
|
-120.34% |
|
-- |
|
-206.10% |
|
-210.51% |
|
$-1.07M |
|
-- |
|
-- |
|
-- |
|
0.45 |
|
0.30 |
|
147.50 |
|
0.61 |
|
15.95% |
|
20.25% |
|
-91.84% |
|
20.39% |
|
$-0.07 |
|
$-0.01 |
|
$-0.01 |
|